Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial
- 15 October 2019
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 106 (1), 100-107
- https://doi.org/10.1016/j.ijrobp.2019.10.010
Abstract
No abstract availableFunding Information
- National Cancer Institute (NCI CA132109, 5P01CA021239)
- National Institutes of Health
- MD Anderson Cancer Center (NCI P30 CA016672)
This publication has 40 references indexed in Scilit:
- Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapyBrain, Behavior, and Immunity, 2010
- Minocycline treatment results in reduced oral steroid requirements in adult asthmaAllergy and Asthma Proceedings, 2008
- Randomized Double-Blind Trial of Prophylactic Oral Minocycline and Topical Tazarotene for Cetuximab-Associated Acne-Like EruptionJournal of Clinical Oncology, 2007
- Minocycline-Induced Cutaneous Polyarteritis NodosaJCR: Journal of Clinical Rheumatology, 2007
- Longitudinal Study of the Relationship Between Chemoradiation Therapy for Non–Small-Cell Lung Cancer and Patient SymptomsJournal of Clinical Oncology, 2006
- Symptom Cluster Research: Conceptual, Design, Measurement, and Analysis IssuesJournal of Pain and Symptom Management, 2006
- Occurrence, Severity, and Longitudinal Course of Twelve Common Symptoms in 1129 Consecutive Patients During Radiotherapy for CancerJournal of Pain and Symptom Management, 2005
- National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002JNCI Journal of the National Cancer Institute, 2003
- Cancer-related symptomsSeminars in Radiation Oncology, 2000
- Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivoCancer Letters, 1994